HIV vaccine trial preparedness among Spanish-speaking Latinos in the US

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 19, Issue 1, 2007, Pages 52-58

  Brooks, R A ^a   Newman, P A ^b   Duan, N ^a   Ortiz, D J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALTRUISM; ARTICLE; CLINICAL ARTICLE; FEMALE; HEALTH CARE ORGANIZATION; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; STIGMA; UNITED STATES;

ADOLESCENT; ADULT; AIDS VACCINES; CLINICAL TRIALS; FEAR; FEMALE; FOCUS GROUPS; GOVERNMENT; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; LOS ANGELES; MALE; MIDDLE AGED; REFUSAL TO PARTICIPATE; TRUST;

EID: 33845287679     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120600872711     Document Type: Article

References (52)

1. AIDS Action (2001). Stigma and prevention. Fact Sheet. Washington DC: AIDS Action.
2. AIDS Alert, American Health Consultants (2001). Fear of disclosure and popular stigmas contribute to bad outcomes (abstract). AIDS Alert, 16, 13.
3. Bogart, L.M., & Thornburn, S. (2005). Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? Journal of Acquired Immune Deficiency Syndromes, 38, 213-218.
4. Brown-Peterside, P., Chiasson, M.A., Ren, L., & Koblin, B.A. (2000). Involving women in HIV vaccine efficacy trials: Lessons learned from a vaccine preparedness study in New York City. Journal of Urban Health, 77, 425-437.
5. Buchbinder, S.P., Metch, B., Holte, S.E., Scheer, S., Coletti, A., & Vittinghoff, E. (2004). Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndromes, 36, 604-612.
6. Caetano, R. (2003). Alcohol-related health disparities and treatment-related epidemiological findings among whites, blacks and Hispanics in the United States. Alcoholism, Clinical and Experimental Research, 27, 1337-1339.
7. Centers for Disease Control and Prevention (2004). National Prevention Information Network: Hispanics and Latinos. Available at: http://www.cdcnpin. org/scripts/population/latino.asp.
8. Cohen, J. (2003). HIV/AIDS: Vaccine results lose significance under scrutiny. Science, 299, 1495.
9. Corbie-Smith, G., Thomas, S.B., Williams, M.V., & Moody-Ayers, S. (1999). Attitudes and beliefs of African Americans toward participation in medical research. Journal of General Internal Medicine, 14, 537-546.
10. Corbie-Smith, G.M. (2004). Minority recruitment and participation in health research. North Carolina Medical Journal, 65, 385-387.
11. Corbie-Smith, G.M., Thomas, S.B., & St. George, D.M. (2002). Distrust, race and research. Archives of Internal Medicine, 162, 2458-2463.
12. Duan, N. (2005). Listening to consumers and HIV vaccine preparedness. Lancet, 365, 1119-1121.
13. Fouad, M.N., Partridge, E., Green, B.L., Kohler, C., Wynn, T., Nagy, S., et al. (2000). Minority recruitment in clinical trials: A conference at Tuskegee, researchers and the community. Annals of Epidemiology, 10(Suppl. 8), S35-S40.
14. Gifford, A.L., Cunningham, W.E., Heslin, K.C., Andersen, R.M., Nakazono, T., Lieu, D.K., et al. (2002). HIV cost and services utilization study consortium: Participation in research and access to experimental treatments by HIV-infected patients. New England Journal of Medicine, 346, 1373-1382.
15. Giuliano, A.R., Mokuau, N., Hughes, C., Tortolero-Luna, G., Risendal, B., Ho, R.C.S., et al. (2000). Participation of minorities in cancer research: The influence of structural, cultural and linguistic factors. Annals of Epidemiology, 10(Suppl. 8), S22-S34.
16. Glaser, B., & Strauss, A. (1967). The discovery of grounded theory. Chicago, Ill: Aldine.
17. Goldin, C.S. (1994). Stigmatization and AIDS: Critical issues in public health. Social Science & Medicine, 39, 1359-1366.
18. Grady, C., Dickert, N., Jawetz, T., Gensler, G., & Emanuel, E. (2005). An analysis of US practices of paying research participants. Contemporary Clinical Trials, 26, 365-375.
19. Guinan, M.E. (1993). Black communities' belief in 'AIDS as genocide': A barrier to overcome for HIV prevention. Annals of Epidemiology, 3, 193-195.
20. Harro, C.D., Judson, F.N., Gorse, G.J., Mayer, K.H., Kostman, J.R., Brown, S.J., et al. (2004). Recruitment and baseline epidemiologic profile of participants in the first Phase 3 HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndrome, 37, 1385-1392.
21. Hepburn, M.J., Hepburn, L.M., Cantu, N.S., Lapeer, M.G., & Lawitz, E.J. (2004). Differences in treatment outcome for hepatitis C among ethnic groups. American Journal of Medicine, 117, 163-168.
22. Herek, G.M., Capitanio, J.P., & Widaman, K.F. (2003). Stigma, social risk and health policy: Public attitudes toward HIV surveillance policies and the social construction of illness. Health Psychology, 22, 533-540.
23. Herek, G.M. (1999). AIDS and stigma. American Behavioral Science, 42, 1106-1116.
24. Hesselbrock, M.N., Hesselbrock, V.M., Segal, B., & Bucholz, K. (2003). Ethnicity and psychiatric comorbidity among alcohol-dependent persons who received inpatient treatment: African Americans, Alaska Natives, Caucasians and Hispanics. Alcoholism, Clinical & Experimental Research, 27, 1368-1373.
25. King, T.E. Jr. (2002). Racial disparities in clinical trials. New England Journal of Medicine, 346, 1400-1402.
26. Klonoff, E.A., & Landrine, H. (1999). Do blacks believe that HIV/AIDS is a government conspiracy against them? Preventative Medicine, 28, 451-457.
27. Kressin, N.R., Meterko, M., & Wilson, N.J. (2000). Racial disparities in participation in biomedical research. Journal of the National Medical Association, 92, 62-69.
28. Londono, E. (2003). Aided by silence, HIV grows among Latinos. Dallas Morning News. October 14, 2003. Taken from: CDC National Prevention Information Network: News Record #38837.
29. Malebranche, D.J. (2003). Black men who have sex with men and the HIV epidemic: Next steps for public health. American Journal Public Health, 93, 862-865.
30. Marin, G., & Marin, B.V.O. (1991). Research with Hispanic populations. In Applied Social Research Methods Series, Vol. 23. Newberry Park: Sage Publications.
31. Mills, E., Cooper, C., Guyatt, G., Gilchrist, A., Rachlis, B., Sulway, C., et al. (2004). Barriers to participating in an HIV vaccine trial: A systematic review. AIDS, 19, 2235-2242.
32. Mirken, B. (1995). AIDS clinical trials: Why they have recruiting problems. Aids.org. AIDS Treatment News, 217. Available at: http://www.aids.org/ atn/a-217-05.html.
33. Montefiori, D.C., Metch, B.M., McElrath, J., Self, S., Weinhold, K.J., Corey, K., et al. (2004). Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines. The Journal of Infectious Diseases, 190, 1962-1969.
34. Moore, B. (2001). Distrust, stigma hinder fight. St. Petersburg Times: July 8, 2001. Available at: http://www.sptimes.com/News/070801/NorthPinellas/ Distrust_stigma_hind.shtml.
35. Morales, L.S., Cunningham, W.E., Galvan, F.H., Andersen, R.M., Nakazono, T.T., & Shapiro, M.F. (2004). Sociodemographic differences in access to care among Hispanic patients who are HIV-infected in the United States. American Journal of Public Health, 94, 1119-21.
36. Morgan, D.L. (1998). The Focus Group Guidebook. Thousand Oaks, CA: Sage Publications.
37. National Institutes of Health (2003). NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Available at: http://grants.nih.gov/grants/funding/women_min/guidelines_update.htm.
38. Newman, P.A., Duan, N., Roberts, K.J., Seiden, D., Rudy, E.T., Swendeman, D., & Popova, S. (2006). HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment. Journal of Acquired Immune Deficiency Syndrome, 41, 210-217.
39. Newman, P.A., Duan, N., Rudy, E.T., & Anton, P.A. (2004). Challenges for HIV vaccine dissemination and clinical trial recruitment: If we build it, will they come? AIDS Patient Care STDS, 18, 691-701.
40. Noah, B.A. (2003). The participation of underrepresented minorities in clinical research. American Journal of Law & Medicine, 29, 221-245.
41. Ross, M.W., Eissen, J.E., & Torres, I. (2006). Conspiracy beliefs about the origin of HIV/AIDS in four racial/ethnic groups. Journal of Acquired Immune Deficiency Syndromes, 41, 342-344.
42. Sengupta, S., Strauss, R.P., DeVellis, R., Quinn, S.C., DeVellis, B., & Ware, W. (2000). Factors affecting African-American participation in AIDS research. Journal of Acquired Immune Deficiency Syndromes, 24, 275-284.
43. Shavers, V.L., Lynch, C.F., & Burmeister, L.F. (2001). Factors that influence African-Americans' willingness to participate in medical research. Cancer, 9(Suppl.), S233-S236.
44. Shavers, V.L., Lynch, C.F., & Burmeister, L.F. (2002). Racial differences in factors that influence the willingness to participate in medical research studies. Annals of Epidemiology, 12, 248-256.
45. Strauss, A., & Corbin, J. (1990). Basics of qualitative research: Grounded theory procedures and techniques. Thousand Oaks: Sage Publications.
46. Strauss, R.P., Sengupta, S., Kegeles, S., McLellan, E., Metzger, D., Eyre, S., et al. (2001). Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three US communities. Journal of Acquired Immune Deficiency Syndromes, 26, 63-71.
47. Stretcher, B.N. (1995). Pharmacokinetic optimization of antiretroviral therapy in patients with HIV infection. Clinical Pharmacokinetics, 20, 46-65.
48. Swartz, A. (2003). Participant protection can increase minority enrollment in clinical trials. HIV Impact, Jan/Feb 2003. Also available at: http://www.omhrc.gov/omh/aids/impact/JanFeb2003.PDF.
49. Thomas, S.B., & Crouse-Quinn, S. (1991). Public health then and now. The Tuskegee syphilis study, 1932-1972: Implications for HIV education and AIDS risk education programs in the Black community. American Journal of Public Health, 81, 1498-1404.
50. US Census Bureau (2003). 2003 American community survey. General characteristics: Hispanic/Latino. Available at: http://factfinder.census.gov/ servlet/SAFFFacts?_sse=/on.
51. US Department of Health & Human Services (2005). HRSA fact sheets: Hispanic and HIV/AIDS, January 2005. Available at: http://hab.hrsa.gov/history/ fact2005/hispanics_and_hivaids.htm.
52. Zhou, H.H., Silberstein, D.J., Wilkinson, G.R., & Wood, A.J.J. (1989). Racial differences in drug response (correspondence). New England Journal Medicine, 321, 257-259.